Northern Trust
BBH icon

Northern Trust’s VanEck Biotech ETF BBH Stock Holding History

Northern Trust’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,100
Closed -$208K – 4410
2025
Q4 		$208K Sell
1,100
-1,020
-48% -$189K ﹤0.01% 3976
2025
Q3 		$351K Buy
+2,120
New +$346K ﹤0.01% 3776
2022
Q2 		– Sell
-2,850
Closed -$462K – 4750
2022
Q1 		$462K Hold
2,850
– – ﹤0.01% 3770
2021
Q4 		$540K Sell
2,850
-257
-8% -$49.6K ﹤0.01% 3779
2021
Q3 		$628K Sell
3,107
-360
-10% -$75.6K ﹤0.01% 3682
2021
Q2 		$699K Sell
3,467
-187
-5% -$34.8K ﹤0.01% 3611
2021
Q1 		$641K Buy
3,654
+300
+9% +$54.2K ﹤0.01% 3743
2020
Q4 		$569K Buy
3,354
+2,053
+158% +$338K ﹤0.01% 3691
2020
Q3 		$211K Buy
+1,301
New +$212K ﹤0.01% 3810

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
CCA
Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Northern Trust's BBH Position: Q1 2026 in Review

Northern Trust sold out of VanEck Biotech ETF (BBH) in Q1 2026, closing a stake of 1,100 shares — an estimated $208K sold.

Northern Trust first reported a position in BBH in Q3 2020 and held it in 9 quarters. The position peaked at $699K in Q2 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Northern Trust reported no remaining VanEck Biotech ETF position as of Q1 2026 after selling out during the quarter.
  • Northern Trust sold 1,100 VanEck Biotech ETF shares in Q1 2026, an estimated $208K.
  • Northern Trust first reported a position in VanEck Biotech ETF in Q3 2020 and held it in 9 quarters.
  • Northern Trust's VanEck Biotech ETF position peaked at $699K in Q2 2021.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.